| MolName | 2-[(2E)-2-(4-bromophenyl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide |
| MolecularFormula | C23H23N3O4BrClS2 |
| Smiles | O=C(CC(C(N1C2CCCCC2)=O)S/C1=N/S(c(cc1)ccc1Br)(=O)=O)Nc(cc1)ccc1Cl |
| InChI | InChI=1S/C23H23BrClN3O4S2/c24-15-6-12-19(13-7-15)34(31,32)27-23-28(18-4-2-1-3-5-18)22(30)20(33-23)14-21(29)26-17-10-8-16(25)9-11-17/h6-13,18,20H,1-5,14H2,(H,26,29)/t20-/m1/s1 |
| InChIK | IKKBOEREGXNTQH-HXUWFJFHSA-N |
| TotalMolweight | 584.942 |
| Molweight | 584.942 |
| MonoisotopicMass | 583.000185 |
| CLogP | 5.231 |
| CLogS | -6.633 |
| H Acceptors | 7 |
| H Donors | 1 |
| TotalSurfaceArea | 373.93 |
| Relative PSA | 0.26387 |
| PolarSurfaceArea | 129.59 |
| Druglikeness | -0.17509 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.52941 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 10 |
| Symmetricatoms | 7 |
| Amides | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - 2-[(2E)-2-(4-bromophenyl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide | 2 - 2-[(2E)-2-(4-bromophenyl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide